focus -WSS

focus

author：Wikipedia 2025-09-03 11:47:17 - browse：7362

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The effects of a landmark ruling on DNA ownership are becoming clearer

explore

knowledge

focus

WSS

Crowdfunding for medical bills sidesteps core problem, author says

ER docs worry over extreme heat as a 'mass casualty event'

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Chemotherapy before breast cancer surgery might fuel metastasis

More hospitals are billing patients as online messages surge

Wikipedia

focus

entertainment

Hollywood unions extend contract negotiations for actors

Chemotherapy before breast cancer surgery might fuel metastasis

Medicare details structure of new drug price negotiation program

Can gargling with Listerine treat gonorrhea of the mouth?

In age of alternative facts, a scholarly course on calling out crap

Why you get paid to donate plasma but not blood

Wildfire smoke exposes gaps in outdoor worker protections

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Alkermes shareholders re

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

focus

Welsh Carson private equity firm escapes from FTC antitrust case

Why you get paid to donate plasma but not blood

Class action alleges UnitedHealth concealed DOJ probe

AltruBio raises $225 million to develop ulcerative colitis drug

Flagship, Pfizer team up in deal worth up to $7 billion

Novel spinal cord stimulator treats paralysis without surgery

explore

knowledge

focus

Wikipedia